ArticleInternational journal of molecular sciences2021

Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners.

Yuika Oouchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.